March 2022

NEPHROLOGY

THE ART OF NEPHROLOGY DURING COVID-19

In a recent editorial published by the American Society of Nephrology (ASN), Susan Quaggin, MD, chief and the Charles H. Mayo, MD, Professor of Medicine in the Division of Nephrology and Hypertension and president of ASN, reflected on the impact COVID-19 has had on the field of nephrology while also applauding the field’s leadership, innovation, research advances and commitment to patient care and advocacy.

“We have witnessed firsthand the major impact of the acute infection and long-term complications from COVID-19 on kidney health. We also understand the increased kidney disease burden that the world will surely face in the coming years,” wrote Quaggin, who is also director of the Feinberg Cardiovascular and Renal Research Institute.

Quaggin wrote that the field should learn from the COVID-19 pandemic to transform and advance all aspects of nephrology, and noted two ways that the field is already improving: by prioritizing kidney health and disease prevention and committing to healthcare justice and access.

“Let us continue to leverage these advances and build on what we’ve learned during the past two years,” Quaggin wrote. “Responding successfully to major crises and being visionary at our core: these efforts represent the art of nephrology.”

​This article was originally published in the Feinberg School of Medicine News Center on March 28, 2022 . 
Susan Quaggin, MD, chief and the Charles H. Mayo, MD, Professor of Medicine in the Division of Nephrology and Hypertension, wrote an editorial published by the American Society of Nephrology.

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​

You May Also Like